University of California, San Francisco | HDFCCC - Hematopoietic Malignancies — San Francisco, California

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies is a clinical research site located in San Francisco, California, United States 94134.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

• UCSF Medical Center-Mission Bay/Benioff Children's Hospital
• University of California-San Francisco Department of Pediatrics - Hematology/Oncology
• UCSF Medical Center - Long Hospital
• Helen Diller Family Comprehensive Cancer Center University of California San Francisco
• University of California, San Francisco - Clinical Research Center
• University of California, Sans Francisco
• San Francisco General Hospital, Clinical Trials Unit
• Department of Neurology, University of California
• Oncology Service of San Francisco General Hospital Medical Center
• University of California at San Francisco Medical Center/Zuckerberg San Francisco General
• University of California San Francisco School of Medicine
• University at San Francisco Medical Center

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, San Francisco | HDFCCC - Hematopoietic Malignancies?

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, San Francisco | HDFCCC - Hematopoietic Malignancies conducted?

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies has 5 clinical trials on record, with 3 currently active. Their work covers Non-small Cell Lung Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma.

Is University of California, San Francisco | HDFCCC - Hematopoietic Malignancies accredited by Crixeo Clinical Trials?

University of California, San Francisco | HDFCCC - Hematopoietic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, San Francisco | HDFCCC - Hematopoietic Malignancies?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.